ArticleBiomedical journal2026

Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis.

Hui-Ling Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.